Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine versus placebo in Parkinson's disease dementia or dementia with Lewy bodies
2005-002038-36Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) comparing Ebixa with Placebo (2 arms). Primary endpoints: Cognition, Behaviour and 4 more. Started Oct 2006; status: completed.
02
Drugs
memantine
03
Conditions
Parkinson's disease dementia (PDD)dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on 2005-002038-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002038-36.